Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey
Tirzepatide (Mounjaro, Zepbound) produces the same transient cortisol testing interference as semaglutide because both medications induce rapid weight loss through GLP-1 receptor agonism
With our nutri+ Sport Essentials, we have developed a product that is perfectly tailored to the needs of demanding training phases
From a safety perspective , taking your injection one day late poses minimal risk
Additionally, you can take our AI quiz here to find the best supplement tailored to your individual needs
Was sollten Sie vor der Anwendung von Minoxidil BIO-H-TIN-Pharma beachten
